JP Morgan Chase
HELP

JP Morgan Chase’s Helus Pharma Inc. Common Stock HELP Stock Holding History

JP Morgan Chase’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
237,828
+235,584
+10,498% +$1.18M ﹤0.01% 4342
2026
Q1 		$9.69K Sell
2,244
-20,199
-90% -$131K ﹤0.01% 6752
2025
Q4 		$184K Buy
22,443
+21,259
+1,796% +$137K ﹤0.01% 5587
2025
Q3 		$3.58K Buy
+1,184
New +$8.39K ﹤0.01% 6830
2024
Q4 		– Sell
-8
Closed -$24 – 7442
2024
Q3 		$24 Hold
8
– – ﹤0.01% 7228
2024
Q2 		$83 Sell
8
-19
-70% -$249 ﹤0.01% 6920
2024
Q1 		$427 Hold
27
– – ﹤0.01% 6738
2023
Q4 		$424 Buy
27
+19
+238% +$354 ﹤0.01% 6949
2023
Q3 		$162 Buy
+8
New +$118 ﹤0.01% 6864
2023
Q1 		– Sell
-474
Closed -$5K – 6780
2022
Q4 		$5K Buy
474
+53
+13% +$874 ﹤0.01% 6152
2022
Q3 		$48K Buy
421
+413
+5,163% +$11.2K ﹤0.01% 5559
2022
Q2 		$1K Buy
+8
New +$194 ﹤0.01% 6345

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

JP Morgan Chase's HELP Position: Q2 2026 in Review

JP Morgan Chase increased its Helus Pharma Inc. Common Stock (HELP) stake by 10,498% in Q2 2026, buying an estimated $1.18M and bringing the position to 237,828 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #4342.

JP Morgan Chase first reported a position in HELP in Q2 2022 and has held it in 12 quarters since. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • JP Morgan Chase held 237,828 shares of Helus Pharma Inc. Common Stock worth $1.64M as of Q2 2026.
  • JP Morgan Chase bought 235,584 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $1.18M.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4342 holding.
  • JP Morgan Chase first reported a position in Helus Pharma Inc. Common Stock in Q2 2022 and has held it in 12 quarters since.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.